“checkpoint-inhibitors” Archives

in
Entry Author Date Location
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
Merck Data Are Another Step for Immunotherapy in Breast Cancer 07/29/19 New York
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer? 05/30/19 National
Kineta Gets $15M in New Cancer Drug Partnership with Pfizer 12/17/18 Seattle
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango 10/31/18 San Francisco
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison, Honjo 10/01/18 National
Akrevia Launches with $30M for Next-Gen Cancer Immunotherapy 09/27/18 Boston
OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies 09/11/18 Texas
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace 04/11/18 National
Incyte, Merck Cancer Trial Failure Damages IDO Drugs’ Prospects 04/06/18 National
Surface Oncology Plans IPO to Advance Clinical Tests of Cancer Drug 03/26/18 Boston
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More 02/16/18 National
With IPO, BioXcel Looks to Fund AI-Fueled Drug Discovery Work 02/14/18 New York
Kyn Nabs $49M to Target Metabolism and Beat Other Cancer Drug Combos 12/14/17 Boston
Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test 11/28/17 New York
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases 11/16/17 Boston
Beloit, Foxconn, Shine, MVI, & More: This Week’s Wisconsin Watchlist 08/08/17 Wisconsin
FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths 07/05/17 New York
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Page 1 of 2 next page »